High level of perforin expression in T cells: An early prognostic marker of the severity of herpesvirus reactivation after allogeneic stem cell transplantation in adults

Clinical Infectious Diseases

Volumn 50, Issue 5, 2010, Pages 717-725

  Pietersma, F L ^a   Van Dorp, S ^a,b   Jacobi, R ^a   Ran, L ^a   Nanlohy, N M ^a   Schuurman, R ^b   Minnema, M C ^b   Meijer, E ^d   Van Baarle, D ^a,c  

^a Wilhelmina Kinderziekenhuis   (Netherlands)

^b Department of Hematology ^*  (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PERFORIN;

ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; DISEASE SEVERITY; FEMALE; HERPES VIRUS INFECTION; HUMAN; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; VIRUS LOAD; VIRUS REACTIVATION;

ADULT; AGED; CD8-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; MALE; MIDDLE AGED; PERFORIN; PROGNOSIS; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; VIRUS ACTIVATION; YOUNG ADULT;

EID: 76749146420     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/650455     Document Type: Article

References (28)

1. Gottschalk S, Rooney CM, Heslop HE. Post-transplant lymphoproliferative disorders. Annu Rev Med 2005; 56:29-44.
2. Hebart H, Einsele H. Clinical aspects of CMV infection after stem cell transplantation. Hum Immunol 2004;65:432-436. (Pubitemid 38686767)
3. Cohen JI. Epstein-Barr virus infection. N Engl J Med 2000; 343:481-492.
4. Reddehase MJ. Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance. Nat Rev Immunol 2002;2:831-844.
5. Babcock GJ, Decker LL, Volk M, Thorley-Lawson DA. EBV persistence in memory B cells in vivo. Immunity 1998;9:395-404. (Pubitemid 28462760)
6. Rickinson AB, Moss DJ. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu Rev Immunol 1997;15:405-431. (Pubitemid 27169287)
7. Meijer E, Boland GJ, Verdonck LE Prevention of cytomegalovirus disease in recipients of allogeneic stem cell transplants. Clin Microbiol Rev 2003; 16:647-657. (Pubitemid 37296553)
8. Pietersma F, Piriou E, van Baarle D. Immune surveillance of EBV-intected B cells and the development of non-Hodgkin lymphomas in immunocompromised patients. Leuk Lymphoma 2008;49:1028-1041. (Pubitemid 351943248)
9. Stevens SJ, Verschuuren EA, Pronk I, et al. Frequent monitoring of Epstein-Barr virus DNA load in untractionated whole blood is essential for early detection of posttransplant lymphoproliterative disease in high-risk patients. Blood 2001;97:1165-1171. (Pubitemid 32183736)
10. van Esser JW, van der Holt. B, Meijer E, et al. Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell-depleted SCT. Blood 2001;98:972-978.
11. Ljungman P, Perez-Bercoff L, Jonsson J, et al. Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantation. Haematologica 2006;91:78-83. (Pubitemid 43235389)
12. Li CR, Greenberg PD, Gilbert MJ, Goodrich JM, Riddell SR. Recovery of'HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis. Blood 1994;83:1971-1979.
13. Lieberman J. The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal. Nat Rev Immunol 2003;3:361-370. (Pubitemid 37323196)
14. Pipkin ME, Lieberman J. Delivering the kiss of death: progress on understanding how perforin works. Curr Opin Immunol 2007; 19:301-308. (Pubitemid 46687016)
15. Hamann D, Baars PA, Rep MH, et al. Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med 1997; 186:1407-1418. (Pubitemid 27479800)
16. van Doornum GJ, Guldemeester J, Osterhaus AD, Niesters HG. Diagnosing herpesvirus infections by real-time amplification and rapid culture. J Clin Microbiol 2003;41:576-580. (Pubitemid 36184164)
17. Meijer E, Spijkers S, Moschatsis S, et al. Active Epstein-Barr virus infection after allogeneic stem cell transplantation: re-infection or reactivation? Transpl Infect Dis 2005;7:4-10.
18. van Baarle B, Wolthers KC, Hovenkamp E, et al. Absolute level of Epstein-Barr virus DNA in human immunodeficiency virus type 1 infection is not predictive of AIDS-related non-Hodgkin lymphoma. J Infect Dis 2002; 186:405-409. (Pubitemid 34816324)
19. Niesters HG, van EJ, Fries E, et al. Development of a real-time quantitative assay for detection of Epstein-Barr virus. J Clin Microbiol 2000; 38:712-715. (Pubitemid 30082668)
20. Heintel T, Sester M, Rodriguez MM, et al. The fraction of perforin-expressing HIV-specific CD8 T cells is a marker for disease progression in HIV infection. AIDS 2002;16:1497-1501. (Pubitemid 34804214)
21. Yoshimi A, Tsuge I, Namizaki H, et al. Epstein-Barr virus-specific T-cell cytotoxicity is mediated through the perforin pathway in patients with lymphoproliterative disorders after allogeneic bone marrow transplantation. Br J Haematol 2002; 116:710-715. (Pubitemid 34178678)
22. Welniak LA, Blazar BR, Murphy WJ. Immunobiology of allogeneic hematopoietic stem cell transplantation. Annu Rev Immunol 2007; 25: 139-170. (Pubitemid 46697905)
23. Griffiths GM, Mueller C. Expression of perforin and granzymes in vivo: potential diagnostic markers for activated cytotoxic cells. Immunol Today 1991; 12:415-1119
24. Rukavina D, Balen-Marunic S, Rubesa G, et al. Perforin expression in peripheral blood lymphocytes in rejecting and tolerant kidney transplant recipients. Transplantation 1996;61:285-291. (Pubitemid 26044545)
25. Veale JL, Liang LW, Zhang Q, et al. Noninvasive diagnosis of cellular and antibody-mediated rejection by perforin and granzyme B in renal allografts. Hum Immunol 2006; 67:777-786. (Pubitemid 44572593)
26. Piriou E, van DK, Otto S, van Oers MH, van Baarle D. Tight regulation of the Epstein-Barr virus setpoint: interindividual differences in Epstein-Barr virus DNA load are conserved after HIV infection. Clin Infect Dis 2008;46:313-316. (Pubitemid 351269175)
27. Meij P, van Esser JW, Niesters HG, et al. Impaired recovery of Epstein-Barr virus (EBV)-specific CD8+ T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative disease. Blood 2003; 101:4290-11297 (Pubitemid 36857791)
28. de Pagter PJ, Schuurman R, Visscher H, et al. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome. Biol Blood Marrow Transplant 2008;14(7):831-839. (Pubitemid 351773160)